Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison

Bos I. S. T., Gosens R., Zuidhof A. B., Schaafsma D., Halayko A. J., Meurs H., Zaagsma J.

Source: Eur Respir J 2007; 30: 653-661
Journal Issue: October
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Bos I. S. T., Gosens R., Zuidhof A. B., Schaafsma D., Halayko A. J., Meurs H., Zaagsma J.. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 2007; 30: 653-661

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice
Source: Eur Respir J 2008; 32: 970-978
Year: 2008



Treating asthma means treating airway smooth muscle cells
Source: Eur Respir J 2008; 32: 265-274
Year: 2008



Inhaled corticosteroids and growth of airway function in asthmatic children
Source: Eur Respir J 2004; 23: 861-868
Year: 2004



Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma
Source: Eur Respir J 2006; 27: 172-187
Year: 2006



Mechanisms of bronchial hyperresponsiveness in a clinical setting – putative role of smooth muscle
Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease
Year: 2005

Allergen-induced airway remodelling
Source: Eur Respir J 2007; 29: 1020-1032
Year: 2007



Inhaled doxycycline reduces allergen-induced airway inflammation, hyperresponsiveness and remodelling in mice
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005


Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
Source: Eur Respir J 2002; 20: 1080-1087
Year: 2002



Basic mechanisms of development of airway structural changes in asthma
Source: Eur Respir J 2007; 29: 379-389
Year: 2007



Effects of salbutamol and enantiomers on allergen-induced asthmatic reactions and airway hyperreactivity
Source: Eur Respir J 2005; 25: 864-872
Year: 2005



Proliferation is not increased in airway myofibroblasts isolated from asthmatics
Source: Eur Respir J 2008; 32: 362-371
Year: 2008



Increased arginase activity contributes to airway remodelling in chronic allergic asthma
Source: Eur Respir J 2011; 38: 318-328
Year: 2011



Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models
Source: Eur Respir J 2008; 32: 487-502
Year: 2008



Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD
Source: Eur Respir J 2003 Dec 01;22(6):926-930
Year: 2003



Increased airway closure is a determinant of airway hyperresponsiveness
Source: Eur Respir J 2008; 32: 1563-1569
Year: 2008



Effect of pinacidil, a KATPCO, on airway hyperresponsiveness and remodeling in guinea-pigs with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 80s
Year: 2004

Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 670s
Year: 2006

Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma
Source: Eur Respir J 2001; 18: 444-450
Year: 2001



Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma
Source: Eur Respir J 2002; 20: 853-858
Year: 2002



Long-term effects of bronchial thermoplasty on airway smooth muscle and collagen deposition in severe asthma
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016